Skip to main content
OpenTrials
Completed

NCT Number: NCT01851967

Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans

This study aims to evaluate efficacy and acceptability of the Chinese language version of MoodGYM as a therapeutic intervention in treating symptoms of depression in community dwelling Chinese Americans in the Boston area.

Hypothesis 1: Participants enrolled in MoodGYM will show a significant decrease in depressive symptoms after completion of the 5 modules.

Hypothesis 2: Participants enrolled in MoodGYM will show significantly improved dysfunctional thinking.

Hypothesis 3: Participants enrolled in MoodGym will rate this program as culturally acceptable.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ying Wang, Beijing, China

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Resident of the US, but self-identified as Chinese origin
  • At least 18 years of age
  • Proficiency in Chinese, including the ability to read Chinese
  • Access to computer and internet
  • Scores > 10 on the Chinese bilingual patient health questionnaire -9 item (PHQ-9)

Exclusion criteria

  • Current ongoing psychiatric or psychological treatment
  • Using illicit drugs or consumption > 3 standard drinks in a day
  • Currently experiencing a psychotic illness
  • Past or current history of schizophrenia or bipolar disorder
  • ECT during the last year
  • Current active suicidal or self-injurious potential necessitating immediate face-to-face treatment

Treatment and study plan

MoodGYM

Other

MoodGYM, a publicly-available online CBT program developed by the Centre for Mental Health Research at The Australian National University has been shown by multiple studies to be effective in reducing symptoms of depression. MoodGYM consists of five interactive modules. Participants will be asked to complete one module each week and progress through the program sequentially.

Primary outcomes

  1. Change in Center for Epidemiologic Studies Depression Scale (CES-D)

    Time frame: Weeks 0, 6 (pre/post)

    The CES-D scale is a short self-report scale designed to measure depressive symptomatology in the general population. Each of the 20 items in this instrument is assigned one value of 0, 1, 2 or 3. High scores on the CES-D indicate high levels of distress.

Sponsors and collaborators

Lead sponsor

Massachusetts General Hospital

Other

Registry information

Important dates

Study start
2014
Primary completion
2015
Study completion
2016
First posted
May 13, 2013
Registry last updated
Dec 1, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.